Staying in Shape - Research Report on Allscripts Healthcare Solutions Inc, Medidata Solutions Inc, Athenahealth, Inc, Cerner Corporation and Cardinal Health, Inc.
NEW YORK, February 26, 2013 /PRNewswire/ --
Today, Investors-Alliance announced new research reports highlighting Allscripts Healthcare Solutions Inc (NASDAQ: MDRX), Medidata Solutions Inc (NASDAQ: MDSO), Athenahealth, Inc (NASDAQ: ATHN), Cerner Corporation (NASDAQ:CERN) and Cardinal Health, Inc. (NYSE: CAH). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Allscripts Healthcare Solutions Inc Research Report
After President Obama signed into law the use of digital medical records, companies like Allscripts saw rising gains. Shares for Allscripts jumped by 12 percent to $12.51 after the company posted its fourth quarter earnings results. Bookings grew quarter-over-quarter to $180.7 million while operating cash flow grew to $222.6 million for the year. The company cites its large, diverse and loyal client base as a factor to help it deliver for clients and investors in the coming year. Analysts also maintain that the company is commendable for its steady growth and its strong market position, being one of the top choices for hospitals that are looking to purchase software for electronic health records (EHR). Jefferies maintained its Hold rating on Allscripts while the ISI Group maintained its Buy rating and raised Allscripts' price target to $14. The Full Research Report on Allscripts Healthcare Solutions Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/08d1_MDRX]
Medidata Solutions Inc Research Report
K&L Consulting Services has expanded its partnership with Medidata Solutions through the Medidata Clinical Cloud. In the terms of the partnership, K&L can now use the Medidata Rave system for electronic data capturing (EDC) and clinical data management (CDM). These technologies will help life science organizations from the US and China increase the efficiency of their clinical trials. Other clients that have recently selected Medidata's technologies also include Endocyte and Sanofi. More healthcare organizations are seeing the advantages of using big data software in increasing the quality of the health care system. In the past year, analysts have also praised Medidata Solutions for its high ROE and operating margins. The Full Research Report on Medidata Solutions Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/3d40_MDSO]
Athenahealth, Inc Research Report
Athenahealth recently reported fourth quarter net income of $5.9 million or 16 cents per share, up 11.5 percent year over year. Revenue also shot up 26 percent year-over-year to $116.3 million. Aside from its strong performance last quarter, the company was also selected by Lowell General Physician Hospital Organization for the company's health information management offering, HDS. The technology will enable Lowell to manage financial, patient and provider data at the same time. In the past months, Athenahealth has captured plenty of clients in the electronic health records (EHR) business and many expect that this trend is likely to continue. Following its strong performance, Athena's stock was upgraded by TheStreet Ratings from Hold to Buy. The Full Research Report on Athenahealth, Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/8175_ATHN]
Cerner Corporation Research Report
Cerner Corporation reported full year revenue of $2.67 billion, up by 21 percent from $2.20 billion in 2011. This increase was attributed to record bookings of 1.02 billion which increased 14 percent year-over-year. Cerner Corporation boasts of clients from the US, Canada, the UK, Australia, Spain, France, and now in the Middle East after King Saudi University chose Cerner Corporation to provide electronic health record systems (EHR) systems for two of their hospitals. Analysts are generally bullish about Cerner Corporation's future, citing its long-term growth opportunities in Healthcare and IT. Jefferies reiterated its Buy rating on Cerner and raised its price target from $82 to $97, citing the overwhelming number of bookings the company received in 2012. Cerner is expected to deliver strongly in the coming year as the company improves its margins and extends its leading R&D position. The Full Research Report on Cerner Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/0a88_CERN]
Cardinal Health, Inc. Research Report
Cardinal Health has announced that it will spend $2 billion to acquire the medical supplier AssuraMed in order to broaden its market to patients who are receiving care at home. AssuraMed is the leading direct-to-home medical supplies distributor, and Cardinal Health states that this acquisition is a natural extension of its business. The transaction is expected to close by early April 2013, with Cardinal Health expecting accretion of 2-3 cents to its existing non-GAAP fiscal 2013 earnings per share guidance range. Investors and analysts approve of the deal, with the company's shares climbing 81 cents to $46.25 after the company announced the acquisition. The Full Research Report on Cardinal Health, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/53ee_CAH]
Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.